Lucas Rosasco Mazzini¹, Daniel Ferreira Paiva¹, Isabela Piza Micelli², Felipe Augusto Ferreira Siquelli², Rafaela Santos Costa², Salvador Affonso Fernandes Pinheiro³, Etore Almir Mattion³ and Hugo Samartine Junior³*

¹Medical Scholar at the Pontifícia Universidade Católica de Campinas (PUC-Campinas), Brazil

²Medical Doctor at the Residency Service in General Surgery at Celso Pierro Hospital and Maternity, PUC-Campinas Hospital, Brazil

³Assistant Physician of the Surgery, Urgency and Trauma Service (SCUT) of the Celso Pierro Hospital and Maternity, PUC-Campinas Hospital, Brazil

*Corresponding Author: Hugo Samartine Júnior, Assistant Physician of the Surgery, Urgency and Trauma Service (SCUT) of the Celso Pierro Hospital and Maternity, PUC-Campinas Hospital, Brazil.

Received: August 05, 2022; Published: September 23, 2022

Abstract

Adrenocortical carcinoma (ACC) is a rare endocrine cancer, with poor prognosis and very aggressive. It has an rare incidence and it’s more prevalent in pediatric and geriatric patients and women. It’s a malignant neoplasy that has diagnostic by complementary exams and needs surgical treatment. May be occur pulmonary, hepatics and bones metastasis during the clinical development.

Keywords: Adrenocortical carcinoma; Adrenal Glands; Adrenalectomy

References

1. Else T., et al. “Adrenocortical carcinoma”. Endocrine Review2 (2014): 282-326.
2. González CTM., et al. “Rapidly evolving adrenal carcinoma”. Review Cuba Endoscopy3 (2013): 270-278.
3. Ahmed AA., et al. “Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management”. Abdominal Radiology4 (2020): 945-963.
4. Vaidya A., et al. “Treatment of adrenocortical carcinoma”. Surgical Pathology Clinics 4 (2019): 997-1006.
5. Edge SB. “American Joint Committee on Cancer - Adrenal Cancer staging manual”. Springer 7 (2010): 97-100.
6. Devita VT., et al. “DeVita, Hellman, and Rosenberg's cancer: principles and practice of oncology”. Lippincott Williams and Wilkins, (2008).
7. Mete O., et al. “Diagnostic and prognostic biomarkers of adrenal cortical carcinoma”. American Journal of Surgical Pathology 2 (2018): 201-213.
8. Freitas ACT. “Carcinoma da glândula supra-renal”. Arquivos Brasileiros de Cirurgia Digestiva 20 (2007): 195-200.
9. Gaujoux S., et al. “Surgical treatment of adrenal carcinoma”. Journal of Visceral Surgery5 (2017): 335-343.
10. Melmed S. “Williams textbook of endocrinology E-book”. Philadelphia: Elsevier Saunder; (2011).
11. Abiven G., et al. “Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients”. The Journal of Clinical Endocrinology and Metabolism7 (2006): 2650-2655.
12. Allolio B., et al. “Management of adrenocortical carcinoma”. Clinical Endocrinology 3 (2004): 273-287.
13. Jasim S and Habra MA. “Management of adrenocortical carcinoma”. Current Oncology Reports 3 (2019): 1-11.
14. Pascual JIP., et al. “Adrenalectomía laparoscópica. Consideraciones a propósito de 24 procedimientos”.
15. Actas Urológicas Españolas2 (2007): 98-105.
16. Dogra S., et al. “Giant virilising adrenal cortical carcinoma”. Autopsy and Case Reports 1 (2021): 11.
17. Didolkar MS., et al. “Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients”. Cancer9 (1981): 2153-2161.

Citation

Citation: Hugo Samartine Júnior., et al. “Malignant Adrenocortical Carcinoma - Case Report". Acta Scientific Gastrointestinal Disorders 5.10 (2022): 17-20.

Copyright

Copyright: © 2022 Hugo Samartine Júnior., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.